Reasons for the classification of off-label drug use in newborns in an intensive care unit.</p
BACKGROUND: Despite major improvements in neonatal care, information on the medication use remain po...
Abstract Background Many newborns may need to be hospitalized and receive drugs during the first day...
Safety and efficacy are essential in the process of disease treatment. However, off-label medication...
Prevalence of newborns administered off-label and unlicensed medicines in an intensive care unit acc...
PURPOSE:To evaluate the use of off-label and unlicensed medicines in a neonatal intensive care unit ...
The use of medicines among newborns admitted to intensive care units is characterized by a high prev...
The lack of specific drugs and labelling recommendations for the neonatal population is a long-stand...
Newborns are particularly susceptible to off-label and unlicensed (OLUL) drug treatments, especially...
On occasions, infants may require the prescription of a medicine that is to be used “off-label ”.The...
Pharmacotherapy of neonates is complex and marked to a large extent of off-label use. The implementa...
The off-label and unlicensed use of drugs in neonatology is a widespread reality in all the NICUs. S...
Newborn or neonate denotes to an infant in the first few days after birth. They are not small childr...
<p><strong>Objetive:</strong> To describe off-label and unlicensed drugs in clinical practice in a N...
Objective To determine the extent of off-label and unlicensed prescribing in hospitalized newborns a...
Objective: To determine the extent of off-label and unlicensed prescribing in hospitalized newborns ...
BACKGROUND: Despite major improvements in neonatal care, information on the medication use remain po...
Abstract Background Many newborns may need to be hospitalized and receive drugs during the first day...
Safety and efficacy are essential in the process of disease treatment. However, off-label medication...
Prevalence of newborns administered off-label and unlicensed medicines in an intensive care unit acc...
PURPOSE:To evaluate the use of off-label and unlicensed medicines in a neonatal intensive care unit ...
The use of medicines among newborns admitted to intensive care units is characterized by a high prev...
The lack of specific drugs and labelling recommendations for the neonatal population is a long-stand...
Newborns are particularly susceptible to off-label and unlicensed (OLUL) drug treatments, especially...
On occasions, infants may require the prescription of a medicine that is to be used “off-label ”.The...
Pharmacotherapy of neonates is complex and marked to a large extent of off-label use. The implementa...
The off-label and unlicensed use of drugs in neonatology is a widespread reality in all the NICUs. S...
Newborn or neonate denotes to an infant in the first few days after birth. They are not small childr...
<p><strong>Objetive:</strong> To describe off-label and unlicensed drugs in clinical practice in a N...
Objective To determine the extent of off-label and unlicensed prescribing in hospitalized newborns a...
Objective: To determine the extent of off-label and unlicensed prescribing in hospitalized newborns ...
BACKGROUND: Despite major improvements in neonatal care, information on the medication use remain po...
Abstract Background Many newborns may need to be hospitalized and receive drugs during the first day...
Safety and efficacy are essential in the process of disease treatment. However, off-label medication...
DOI
Add to ORKG